Welcome to our dedicated page for Bio Green Med Solution SEC filings (Ticker: BGMS), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on Bio Green Med Solution's stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.
Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time EDGAR feed updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into Bio Green Med Solution's regulatory disclosures and financial reporting.
Bio Green Med Solution (BGMS): A reporting person filed a Form 4 showing an open‑market sale of common stock. On 10/14/2025, the filer sold 135,793 shares at $6 per share (Transaction Code S). Following the transaction, the filer reported 268,672 shares beneficially owned with direct ownership.
Bio Green Med Solution (BGMS) reported an insider transaction on a Form 4. A 10% owner sold 51,400 shares of common stock on 10/10/2025 at $5.258 per share (Transaction Code: S). Following the sale, the reporting person beneficially owned 505,758 shares, held directly. The filing was made by /s/ Datuk Tan Chor How Christopher on 10/14/2025.
Report overview: This Schedule 13G/A states that Kua Khai Loon beneficially owns 805,695 shares of Bio Green Med Solution, Inc. common stock, representing 16.35% of the class. The filing breaks ownership into 338,160 common shares and warrants totaling 467,535 (218,000 Series A warrants, 218,000 Series B warrants, and 31,535 Series C warrants) that are exercisable into common stock.
The filer certifies the shares were not acquired to change or influence control. The document lists the issuer's Kuala Lumpur address and the reporter's Malaysian residence, and it attaches warrant forms as exhibits.
Bio Green Med Solution (BGMS) filed a Form 4 reporting insider stock sales by Kua Khai Loon, a Director. On 09/12/2025, the insider sold 22,251 shares of common stock at $6.224 per share, leaving 363,160 shares beneficially owned. On 09/16/2025, the insider sold an additional 25,000 shares at $5.132 per share, with 338,160 shares beneficially owned afterward. Both positions are listed as Direct (D) ownership.
FITTERS Diversified Berhad, a director, reported a sale of
FAQ
What is the current stock price of Bio Green Med Solution (BGMS)?
What is the market cap of Bio Green Med Solution (BGMS)?
